United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0227_2a9aec09-6306-2252-e063-6294a90a204a
- Product NDC
- 80425-0227
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230111
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, UNIT-DOSE (80425-0227-1) · 80425-0227-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →